Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)
<p>Abstract</p> <p>Background</p> <p>Allogeneic hematopoietic stem cell transplantation (HSCT) for patients with Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR1) is much more intensive than multi-agent combined c...
Main Authors: | Nagafuji Koji, Miyamoto Toshihiro, Eto Tetsuya, Kamimura Tomohiko, Taniguchi Shuichi, Okamura Takashi, Ohtsuka Eiichi, Yoshida Takashi, Higuchi Masakazu, Yoshimoto Goichi, Fujisaki Tomoaki, Abe Yasunobu, Takamatsu Yasushi, Yokota Shouhei, Akashi Koichi, Harada Mine |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-02-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://www.jhoonline.org/content/6/1/14 |
Similar Items
-
P1402: INFUSION OF 14 DAYS BLINATUNOMAB IN COMBINATION WITH CHEMOTHERAPY FOR 46-DAY MRD+ PEDIATRIC B-ALL PATIENTS IN INTERMEDIATE/HIGH-RISK GROUP RESULTS IN MRD CONVERSION.
by: Changwen Xue, et al.
Published: (2023-08-01) -
Evaluation of CD30 expression in B ALL and its correlation with MRD(Minimum Residual Disease)
by: Amirhossein Kazemian, et al.
Published: (2021-01-01) -
HOW TO INCORPORATE MRD IN CLINICAL TRIALS
by: Jesus San-Miguel
Published: (2022-04-01) -
MRD in AML: The Role of New Techniques
by: Maria Teresa Voso, et al.
Published: (2019-07-01) -
Changes in MRD's Team of Editors-in-Chief
by: Susanne Wymann von Dach, et al.
Published: (2021-08-01)